Persistent pulmonary hypertension of the newborn and smoking and aspirin and nonsteroidal antiinflammatory drug consumption during pregnancy

Pediatrics

Volumn 97, Issue 5, 1996, Pages 658-663

  Van Marter, Linda J ^a,b,c,f   Leviton, Alan ^c,f   Allred, Elizabeth N ^c,d   Pagano, Marcello ^c,d   Sullivan, Kathleen F ^a   Cohen, Aaron ^b,e   Epstein, Michael F ^a,f  

^a Department of Pediatrics   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e Health Effects Institute   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

aspirin; diabetes mellitus; drug abuse; hypertension, pulmonary; newborn infant, diseases; nonsteroidal antiinflammatory drugs; persistent fetal circulation; smoking; socioeconomic status

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; CONTROLLED STUDY; DRUG USE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN DISEASE; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RISK ASSESSMENT; SMOKING; STATISTICAL ANALYSIS;

ADULT; ANOXEMIA; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; COCAINE; CONFOUNDING FACTORS (EPIDEMIOLOGY); EDUCATIONAL STATUS; FEMALE; FETAL DISEASES; HUMANS; INFANT, NEWBORN; LOGISTIC MODELS; MALE; MARIJUANA SMOKING; MEDICAID; MULTIVARIATE ANALYSIS; PERSISTENT FETAL CIRCULATION SYNDROME; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS; PROSTAGLANDIN ANTAGONISTS; SMOKING; SUBSTANCE-RELATED DISORDERS; UNITED STATES; VASOMOTOR SYSTEM;

EID: 0029873317     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Heyman M, Soifer S Persistent pulmonary hypertension of the new-born. In: Fishman A, ed The Pulmonary Circulation: Normal and 'bnormal. Philadelphia: University of Pennsylvania Press, 1990:372
2. Gersony WM, Due GV, Sinclair JC. "PFC" syndrome (persistence of the fetal circulation). Circulation. 1969;39(suppl III):87
3. Murphy JD, Rabinovitch M, Goldstein JD, Reid LM The structural basis of persistent pulmonary hypertension of the newborn infant J Pedtatr 1981;98:962-967
4. Goldberg SJ, Levy RA, Siassi B, Betten J. The effects of maternal hypovia and hyperoxia upon the neonatal pulmonary vasculature. Pediatrics 1971:48-528-533
5. Mecham RP, Whitehouse LA, Wrenn DS, Parks WC. Smooth musclemediatcd connective tssue remodeling in pulmonary hypertension. Science. 1987;237:423-426
6. Levin DL, Mills LJ, Weinberg AG. Hemodynamic, pulmonary vascular, and myocardial abnormalities secondary to pharmacologic constriction of the fetal ductus arteriosus. Circulation. 1979;60 360-364
7. Harker LC, Kirkpatrick SE, Friedman WF, Bloor CM. Effects of indomethacin on fetal rat lungs: a possible cause of persistent fetal circulation Pediatr Res, 1981,15:147-151
8. Socol ML, Manning FA, Murata Y, Druzin ML. Maternal smoking causes fetal hypoxia: experimental evidence. Am J Obstet Gynecol. 1982; 142-214-218
9. Manchester D, Margolis HS, Sheldon RE Possible association between maternal indomethacin therapy and primary pulmonary hypertension of the newborn. Am J Obstet Gynecol 1976;126:467-469
10. Csaba IF, Sulyok E, Ertl T. Relationship of maternal treatment with indomethacin to persistence of fetal circulation syndrome. J Pediatr. 1978;92:484
11. Goudie BM, Dossetor JFB. Effect on the fetus of indomethacin given to suppress labour Lancet, 1979;2:1187-1188
12. Rubaltelli FF, Chiozza ML, Zanardo V, Cantarutti F. Effect on neonate of maternal treatment with indomethacin. J Pediair. 1979;94:161
13. Besinger RE, Niebyl JR, Keyes WG, Johnson TRB. Randomized comparative trial of indomethacin and ritodrine for the long-term treatment of preterm labor. Am J Obstet Gynecol 1991;164:981-988
14. Sharpe GL, Larsson KS, Thalme B. Studies on closure of the ductus arteriosus. XII. In utero effect of indomethacin and sodium salicylate in rats and rabbits. Prostaglandins, 1975;9:585-596
15. Levin DL, Mills LJ, Parkey M, Garriott J, Campbell W. Constriction of the fetal ductus arteriosus after administration of indomethacin to the pregnant ewe. J Pediatr. 1979;94:647-650
16. Moise KJ, Huhta JC, Sharif DS, et al. Indomethacin in the treatment of premature labor. N Engl J Med. 1988;319:327-331
17. Woods JR, Plessinger MA, Clark KE Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA. 1987;257:957-961
18. Chokshi SK, Gal D, Whelton JA, Isner JM. Evidence that fetal distress in newborns of cocaine users is due to vascular spasm and may be attenuated by pre-treatment with diltiazem. Circulation. 1989;80(suppl II):185
19. Nelson K, Holmes LB. Malformations due to presumed spontaneous mutations in newborn infants. N Engl J Med. 1989;320:19-23
20. Heymann MA, Rudolph AM. Effects of acetylsalicylic acid on the ductus arteriosus and circulation in fetal lambs in utero. Circ Res. 1976;38: 418-422
21. Wilkinson AR, Aynsley-Green A, Mitchell MD. Persistent pulmonary hypertension and abnormal prostaglandin E levels in preterm infants after maternal treatment with naproxen. Arch Dis Child. 1979;54.942-945
22. Norton ME, Merrill J, Cooper BAB, Kuller JA, Clyman RI. Neonatal complications after the administration of indomethacin for preterm labor. N Engl J Med. 1993;329:1602-1607
23. Levin DL, Fixier DE, Morriss FC, Tyson J. Morphologic analysis of the pulmonary vascular bed in infants exposed in utero to prostaglandin synthetase inhibitors J Pediatr. 1978;92:478-483
24. Dalens B, Dechelotte P, Raynaud EJ. Utilisation obstétricale de l'indométacine et risques d'hypertension artérielle pulmonaire néonatale sévère. Arch Fr Pediatr. 1981;38:261-265
25. Arcilia RA, Thilenius OG, Ranntiger K. Congestive heart failure from suspected ductal closure in utero. J Pediatr. 1969;75:74-78
26. Perkin RM, Levin DL, Clark R: Serum salicylate levels and right-to-left ductus shunts in newborn infants with persistent pulmonary hypertension. J Pediatr. 1980;96:721-726
27. 2 to prostacyclin in relatively high risk pregnancies N Engl J Med. 1989;321:351-356
28. Benigni A, Gregorini G, Frusca T, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engt J Med. 1989;321: 357-362
29. Sibat BM, Caritis SN, Thom E, et al. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. N Engl J Med. 1993;329:1213-1218
30. Meyer MB, Jonas BS, Tonascia JA. Perinatal events associated with maternal smoking during pregnancy Am J Epidermal 1976;103:464-476
31. Malloy MH, Kleinman JC, Land GH, Schramm WF. The association of maternal smoking with age and cause of infant death. Am J Epidemiol. 1988;128:46-55
32. Bearer CF, Roitman E, Gemmel D. Persistent pulmonary hypertension and maternal smoking. Pediatr Res. 1993;33:255A. Abstract
33. Gersony WM, Morishima HO, Daniel SS, Kohl S. The hemodynamic effects of intrauterine hypoxia: an experimental model in newborn lambs. J Pediatr. 1976;89:631-635
34. Abman SH, Accurso FJ, Wilkening RB, Meschia G. Persistent fetal pulmonary hypoperfusion after acute hypoxia. Am J Physiol. 1987;253: H941-H948
35. Custer JR, Hales CA. Influence of alveolar oxygen on pulmonary vasoconstriction in newborn lambs versus sheep. Am Rev Respir Dis. 1985; 132:326-331
36. Belik J, Sienko A, Light RB. The effect of repeated intermittent hypoxia on pulmonary vasoconstriction in the newborn. Can J Physiol Pharmacol. 1990;68:355-362
37. Christianson RE. Gross differences observed in the placentas of smokers and nonsmokers. Am J Epidemiol. 1979;110:178-187
38. Naeye RL. Abruptio placentae and placenta previa: frequency, perinatal mortality, and cigarettte smoking. Obstet Gynecol. 1980;55:701-704
39. Asmussen I. Ultrastructure of the villi and fetal capillaries in placentas from smoking and nonsmoking mothers. Br J Obstel Gynaecol. 1980;87: 239-245
40. Mochizuki M, Maruo T, Masuko K, Ohtsu T. Effects of smoking on fetoplacental-maternal system during pregnancy. Am J Obstet Gynecol. 1984;149:413-420
41. Philipp K, Pateisky N, Endler M. Effects of smoking on uteroplacental blood flow Gynecol Obstet Invest. 1984;17:179-182
42. Suzuki K, Minei LJ, Johnson EE. Effect of nicotine upon uterine blood flow in the pregnant rhesus monkey. Am J Obstet Gynecol. 1980;136: 1009-1013
43. Van Vunakis H, Langone JJ, Milunsky A. Nicotine and cotinine in the amniotic fluid of smokers in the second trimester of pregnancy. Am J Obstet Gynecol. 1977;120:64-66
44. Etzel RA, Greenberg RA, Haley NJ, Loda FA. Urine cotinine excretion in neonates exposed to tobacco smoke products in utero. J Pediatr 1985; 107:146-148
45. Busacca M, Breviario F, Agarossi A, Vignali M, de Gaetano G, Dejana E. Effect of cigarette smoking on plasmatic regulation of vascular prostacyclin in pregnancy and puerperium. Obstet Gynecol. 1986;68:816-819
46. Ahlsten G, Ewald U, Tuvemo ET. Prostacyclin-like activity in umbilical arteries is dose-dependently reduced by maternal smoking and related to nicotine levels Biol Neonate. 1990;58:271-278
47. Bauman KE, Ennett S. Tobacco use by black and white adolescents: the validity of self reports. Am J Public Health. 1994;84:394-398
48. Miettienen O Efficacy of therapeutic practice: will epidemiology provide the answers? In: Melmon KL, ed. Drug Therapeutics Concepts for Physicians. New York. Elsevier, 1981:201-208
49. Gibson RL, Truog WE, Redding GJ Thromboxane-associated pulmonary hypertension during three types of gram-positive bacteremia in piglets. Pediatr Res. 1988;23:553-556
50. Hammerman C, Komar K, Abu-Khudair H. Hypoxie vs septic pulmonary hypertension. Am J Dis Child. 1988;142:319-325
51. Werler MM, Pober B, Nelson K, Holmes L Reporting accuracy among mothers of malformed and nonmalformed infants Am J Epidemiol. 1989;129:415-421
52. MacKenzie S, Lippman A. An investigation of report bias in a case control study of pregnancy outcome. Am J Epidemiol. 1989;129:65-75